HomeALGS • NASDAQ
add
Aligos Therapeutics Inc
Previous close
$4.72
Day range
$4.35 - $4.97
Year range
$3.76 - $46.80
Market cap
27.15M USD
Avg Volume
181.59K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 629.00K | -76.54% |
Operating expense | 5.16M | -9.41% |
Net income | -82.15M | -194.53% |
Net profit margin | -13.06K | -1,155.37% |
Earnings per share | -13.10 | -138.18% |
EBITDA | -20.32M | 18.32% |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 56.94M | -58.04% |
Total assets | 70.09M | -53.74% |
Total liabilities | 99.07M | 66.65% |
Total equity | -28.97M | — |
Shares outstanding | 6.11M | — |
Price to book | -0.63 | — |
Return on assets | -64.86% | — |
Return on capital | -266.15% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -82.15M | -194.53% |
Cash from operations | -18.40M | 18.78% |
Cash from investing | 19.97M | 285,414.29% |
Cash from financing | 97.00K | -99.89% |
Net change in cash | 1.67M | -97.45% |
Free cash flow | -10.08M | 17.06% |
About
Founded
2018
Headquarters
Website
Employees
70
